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The pfcrt allelic type and adjacent microsatellite marker type were determined for 82 Plasmodium falciparum
isolates from the Philippines. Mutant pfcrt allelic types P1a and P2a/P2b were dominant in different locations.
Microsatellite analysis revealed that P2a/P2b evolved independently in the Philippines, while P1a shared
common ancestry with Papua New Guinea chloroquine-resistant parasites.
Mutations in the pfcrt gene have been associated with chlo-
roquine resistance in Plasmodium falciparum (4, 6, 8, 12). Fif-
teen amino acid mutations at positions 72, 74, 75, 76, 97, 144,
148, 160, 194, 220, 271, 326, 333, 356, and 371 have been
identified in pfcrt of chloroquine-resistant (CQR) parasites
from various regions (3, 7–9, 15). In general, the CQR isolates
from Southeast Asia and Africa have pfcrt alleles with seven to
nine mutated codons that are linked to a pattern of C/I/E/T/
H(L)/A(F)/L(I)/L/I(T)/S/E/S/T(S)/T/I (boldface italics indicate
the mutated codons), from positions 72 to 371, while the CQR
parasites from South America and Papua New Guinea (PNG)
possess pfcrt alleles with four or five mutated codons forming a
pattern of S(C)/M/N/T/H/A/L/L/I/S/Q/D/T/L/R (3, 4, 8, 9, 15).
Our previous study identified novel pfcrt allelic types in para-
sites from Morong, the Philippines, with four or five mutated
amino acids linked into a pattern of S(C)/M/N/T/H/T/L/Y/I/A/
Q/D/T/I/R. In vitro chloroquine susceptibility testing indicated
that these parasites with the novel pfcrt allelic types were CQR
(3). Among the mutated codons, A144T and L160Y were ex-
clusively identified in the Philippine isolates, suggesting that
CQR pfcrt alleles evolved independently in the Philippines (3).
The novel Philippine pfcrt allelic types were named P2a and
P2b according to the nomenclature used by Wellems and
Plowe (3, 14).
In this study, we analyzed pfcrt allelic types in P. falciparum
isolates from several locations within the Philippines to ascer-
tain the geographical distribution of these novel and other pfcrt
allelic types. The ancestral origin of the observed CQR pfcrt
allelic types was investigated by microsatellite marker analysis
(15).
Eighty-two P. falciparum isolates were collected from the
following locations in the Philippines between 1989 and 2002
(Fig. 1): Morong (n 20) (3), Bagac (n 4), and Dinalupiham
(n  12) in Bataan Province, Central Luzon; Puerto Princesa,
Palawan (n  12), and Tayabas (n  6) in Quezon Province,
South Luzon; Conner (n  10) and Kabugao (n  5) in Kal-
inga-Apayao Province, Northern Luzon; and Agusan del Sur,
Mindanao (n  13). Genomic DNA was extracted using a
Wizard Plus Minipreps DNA Purification System (Promega),
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FIG. 1. Locations in the Philippines where parasite isolates were
examined for pfcrt allelic types and microsatellite marker types. Num-
bers in parentheses following the name of a district/municipality indi-
cate the total number of parasite samples. pfcrt allelic types and num-
bers detected at each location are indicated below the name of each
district/municipality.
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TABLE 1. pfcrt allelic types and polymorphisms in microsatellite markers flanking pfcrt in P. falciparum samples collected from different
districts/municipalities in the Philippines compared to those from other areas
Origin (total no. of isolates)
and sample
No. of
isolates %
MSb marker size (bp)
PFCRT (allelic type)a
MS marker size (bp)
B5M77
(20 kb)
2F10
(5 kb)
PE12A
(6 kb)
2H4
(22 kb)
PE14F
(106 kb)
Philippines
Morong (20)
PH1 group 18 90 149 182 CMNTHTYAQDLR (P2a) 314 228 136
PH2 1 5 149 182 SMNTHTYAQDIR (P2b) 314 228 136
PH4 1 5 149 170 CIETHALSESTI (E1a) 314 204 145
Bagac (4), B1 group 4 100 149 182 CMNTHTYAQDLR (P2a) 314 228 136
Dinalupiham (12)
D1 group 10 83 149 182 CMNTHTYAQDLR (P2a) 314 228 136
D16 1 8 149 182 CMNTHTYAQDLR (P2a) 314 220 142
D3 1 8 149 182 SMNTHTYAQDIR (P2b) 314 228 136
Palawan (12)
PAL2 group 5 42 149 182 SMNTHTYAQDIR (P2b) 314 228 136
PAL12 group 2 17 149 182 SMNTHTYAQDIR (P2b) 314 228 151
PAL7 1 8 149 182 SMNTHTYAQDIR (P2b) 314 228 148
PAL6 1 8 149 182 SMNTHTYAQDIR (P2b) 314 220 136
PAL5 group 2 17 147 194 SMNTHALSQDLR (P1a) 328 228 136
PAL1 1 8 147 194 SMNTHALSQDLR (P1a) 328 228 148
Tayabas (6)
T1 group 2 33 149 174 SMNTHALSQDLR (P1a) 328 218 148
T4 1 17 149 174 SMNTHALSQDLR (P1a) 328 184 148
T2 group 2 33 149 182 SMNTHTYAQDIR (P2b) 314 228 136
T3 1 17 149 176 CMNKHALAQNIR (CQS) 328 182 142
Mindanao (13)
L104 group 4 31 149 174 SMNTHALSQDLR (P1a) 328 184 148
L088 group 2 15 149 174 SMNTHALSQDLR (P1a) 328 184 151
L016 1 8 149 174 SMNTHALSQDLR (P1a) 328 184 142
M013 group 2 15 149 174 SMNTHALSQDLR (P1a) 328 206 148
M007 1 8 149 174 SMNTHALSQDLR (P1a) 328 186 148
X039 1 8 149 174 SMNTHALSQDLR (P1a) 328 204 148
X098 1 8 149 182 SMNTHTYAQDIR (P2b) 314 202 148
X097 1 8 149 182 SMNTHTYAQDIR (P2b) 314 202 151
Connor (10)
C3 group 7 70 149 174 SMNTHALSQDLR (P1a) 328 184 148
C1 group 3 30 149 174 SMNTHALSQDLR (P1a) 328 228 136
Kabugao (5), Kab1 group 5 100 149 174 SMNTHALSQDLR (P1a) 328 184 148
Other areas
Brazil (1), 7G8 1 151 190 SMNTHALSQDLR (W1a) 314 194 142
Thailand (5)
Dd2 group 2 149 170 CIETHALSESTI (E1a) 314 204 145
K1 1 149 170 CIETHALSESII (E1b) 314 204 145
TM93-C1088 1 149 170 CIETLALSESTI (E1c) 314 204 145
C2B 1 149 170 CIETHALSESTI (E1a) 314 184 148
Solomon (4)
N18 group 2 149 174 SMNTHALSQDLR (P1a) 328 184 142
N70 group 2 147 174 SMNTHALSQDLR (P1a) 328 184 142
PNG (6)
AN001 group 4 149 174 SMNTHALSQDLR (P1a) 328 184 142
AN018 group 2 149 174 SMNTHALSQDLR (P1a) 328 192 139
a Amino acid positions in PFCRT shown are 72, 74, 75, 76, 97, 144, 160, 220, 271, 326, 356, and 371. pfcrt allelic types E, W, and P refer to resistant loci originating
in the eastern and western hemispheres and in the Pacific, respectively (3, 14).
b MS, microsatellite.
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and DNA fragments covering the 12 known mutations in pfcrt
were amplified by PCR (3). PCR products were purified with a
NucleoSpin extraction kit (Macherey-Nagel) and sequenced.
Microsatellite markers flanking the pfcrt gene, B5M77(20
kb), 2E10 (5 kb), PE12A (6 kb), 2H4 (22 kb), and PE14F
(106 kb), were amplified and analyzed as previously de-
scribed (15).
Polymorphisms in pfcrt in P. falciparum collected from the
Philippines are shown in Table 1. Novel pfcrt allelic types P2a
and P2b with mutations at A144T and L160Y were identified
in 18/20 and 1/20 Morong isolates (Central Luzon) (3), respec-
tively. P2a was also the major pfcrt allelic type in Bagac (4/4)
and Dinalupiham (11/12) in Central Luzon, while P2b was the
major type in Puerto Princesa, Palawan (9/12). In comparison,
P2b was only identified in a small proportion of the isolates
from Tayabas (2/6) in Southern Tagalog and from Agusan del
Sur, Mindanao (2/13). Neither P2a nor P2b was detected in
isolates from Conner and Kabugao, Northern Luzon, where
P1a, the PNG allelic type, dominated. The chloroquine-sensi-
tive wild-type pfcrt was detected in one isolate from Tayabas.
Overall, among the 82 Philippine isolates analyzed, 48 (58.5%)
possessed the P2a/P2b alleles, 32 (39%) had the P1a allele, and
1 (1.2%) each had the E1a allele and the wild type.
Genotyping using msp1, msp2, and glurp (10) was performed
to examine the heterogeneity of the isolates on loci not linked
with pfcrt. Various banding patterns were observed among
isolates with identical novel P2a and P2b pfcrt allelic types,
indicating the isolates were diverse rather than clonal (data not
shown). This is highlighted in 18 Morong isolates, where nine
distinct banding patterns identified for msp1, msp2, and glurp
corresponded to the P2a pfcrt allele.
The dissemination of mutant pfcrt allelic types in the Phil-
ippines is shown in Fig. 1. P2a was the major type in isolates
from Central Luzon, while P2b predominated in those from
Palawan. P1a was found to be dominant in isolates from North-
ern Luzon and Mindanao. Although geographically the prov-
inces of Bataan and Quezon are situated in Luzon, they are
well separated by mountain ranges. This may provide an ex-
planation for the dominance of P2a and P1a, respectively, in
these provinces. Palawan, though separated by sea, shares a
closely related dominant pfcrt allelic type with Central Luzon.
The novel mutations in P2a and P2b alleles (A144T and
L160Y) were not found in a wild-type pfcrt gene, indicating
that these mutations in the CQR isolates were not inherited
from chloroquine-susceptible parasites in the Philippines. In
addition, none of the Philippine isolates with A144T and
L160Y mutations (n  48) carried the A220S mutation very
commonly seen in CQR parasites elsewhere. The mutually
exclusive presence of A144T/L160Y with A220S suggests that
A144T and L160Y may play a similar role as A220S in CQR.
Five microsatellite markers flanking the pfcrt gene, B5M77,
2E10, PE12A, 2H4, and PE14F (15), were analyzed for all the
Philippine isolates included in this study, as well as several
standard laboratory lines and isolates from Southeast Asia,
Oceania, and South America. As shown in Table 1, all isolates
with the P2a pfcrt allele, except for one from Dinalupiham
(D16), gave the identical size for all five microsatellite markers,
and the banding pattern was unique compared to that in par-
asites from other regions. While some isolates with the P2b
pfcrt allele had microsatellite markers identical to those in P2a,
others showed variations in some microsatellite markers. The
unique microsatellite marker patterns of P2a/P2b pfcrt allelic
types demonstrate that P2a/P2b alleles evolved independently
in the Philippines. The similarity between the microsatellite
patterns of P2a and P2b and fact that P2b carried an extra
mutation (C72S) suggest that the P2b allelic type was derived
from P2a. We hypothesize that CQR parasites (P2a) originated
in Central Luzon and spread south to Palawan and Mindanao
with the addition of an extra mutation in pfcrt (P2b). This is
consistent with field observation of chloroquine resistance in Phil-
ippines: first documented in Luzon from the early 1970s to the
1980s (2, 5, 11, 13) and subsequently in Palawan (1).
In contrast, the microsatellite marker patterns of the Phil-
ippine isolates with P1a pfcrt type closely resembled that of the
PNG and the Solomon Islands isolates, suggesting that P1a
pfcrt alleles in parasites from the Philippines and Oceania
evolved from a common origin and may have spread from
neighboring countries. The only Philippine isolate with the E1a
pfcrt type (PH4) was identical to Dd2 (Thailand) in microsat-
ellite marker pattern (Table 1). Significantly, this was obtained
in close proximity to the site of the main transit camp for
Indochinese refugees in the Philippines.
This study confirms that at least two founder events of chlo-
roquine resistance have occurred in the Pacific region, one in
PNG and one in the Philippines, and demonstrates that under
chloroquine selection pressure, P. falciparum parasites with
various genetic backgrounds have developed chloroquine re-
sistance independently by mutating different positions in the
pfcrt gene.
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